Opinion

Video

Guidance for Moving to Advanced Systemic Therapy and Biologic Agents

Panelists discuss recent guideline changes regarding advanced systemic therapy in atopic dermatitis (AD), focusing on when to transition a patient to systemic agents and when biologics should be considered for the treatment of moderate to severe AD.

Video content above is prompted by the following:

  • Discuss changes in patients’ quality of life with atopic dermatitis treatments.
  • Recent changes in guidelines and moving to advanced systemic therapy in AD.
  • When would you transition a patient to systemic agents? When should biologics be considered for treatment of moderate to severe AD? 

Related Videos
Safety Profile, Accessibility of Tapinarof Cream for Atopic Dermatitis, with Adelaide Hebert, MD
Impact of Tapinarof Cream Approval for Atopic Dermatitis, with Adelaide Hebert, MD
Sobia Laique, MD | Credit: Cleveland Clinic
Sobia Laique, MD | Credit: Cleveland Clinic
What is the Global Lung Function Initiative and Its Purpose for Lung Function Testing?
Greg A. Sachs, MD I Credit: Regenstrief Institute
3 experts are featured in this series.
3 experts are featured in this series.
© 2025 MJH Life Sciences

All rights reserved.